CSAD
Cysteine sulfinic acid decarboxylase
Also known as: CSAD_HUMAN, CSD, PCAP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y600
- Gene
- CSAD
- Ensembl
- ENSG00000139631
- Chromosome
- 12
- Canonical length
- 493 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum,Vesicles,Plasma membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the group 2 decarboxylase family. A similar protein in rodents plays a role in multiple biological processes as the rate-limiting enzyme in taurine biosynthesis, catalyzing the decarboxylation of cysteinesulfinate to hypotaurine. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
493 residues, UniProt reviewed canonical sequence.
>Q9Y600|CSAD
1 MADSEALPSL AGDPVAVEAL LRAVFGVVVD EAIQKGTSVS QKVCEWKEPE ELKQLLDLEL
61 RSQGESQKQI LERCRAVIRY SVKTGHPRFF NQLFSGLDPH ALAGRIITES LNTSQYTYEI
121 APVFVLMEEE VLRKLRALVG WSSGDGIFCP GGSISNMYAV NLARYQRYPD CKQRGLRTLP
181 PLALFTSKEC HYSIQKGAAF LGLGTDSVRV VKADERGKMV PEDLERQIGM AEAEGAVPFL
241 VSATSGTTVL GAFDPLEAIA DVCQRHGLWL HVDAAWGGSV LLSQTHRHLL DGIQRADSVA
301 WNPHKLLAAG LQCSALLLQD TSNLLKRCHG SQASYLFQQD KFYDVALDTG DKVVQCGRRV
361 DCLKLWLMWK AQGDQGLERR IDQAFVLARY LVEEMKKREG FELVMEPEFV NVCFWFVPPS
421 LRGKQESPDY HERLSKVAPV LKERMVKEGS MMIGYQPHGT RGNFFRVVVA NSALTCADMD
481 FLLNELERLG QDLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CSAD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 92 nTPM
Expression across tissuesHPA
Tissue
- liver: 92 nTPM
- adipose tissue: 60 nTPM
- breast: 57 nTPM
- skin: 55 nTPM
- ovary: 49 nTPM
- epididymis: 48 nTPM
Single-cell type
- adipocytes: 240 nCPM
- pituicytes/fscs: 153 nCPM
- choroid plexus epithelial cells: 153 nCPM
- neutrophils: 116 nCPM
- undifferentiated spermatogonia: 109 nCPM
- prostatic glandular cells: 104 nCPM
Immune cell
- neutrophil: 16 nTPM
- basophil: 3.7 nTPM
- T-reg: 3.4 nTPM
- eosinophil: 2.5 nTPM
- naive CD4 T-cell: 2.4 nTPM
- plasmacytoid DC: 2.3 nTPM
Brain region
- white matter: 63 nTPM
- choroid plexus: 59 nTPM
- medulla oblongata: 44 nTPM
- basal ganglia: 42 nTPM
- pons: 41 nTPM
- cerebellum: 41 nTPM
ReferencesPubMed · IEDB
Publications for CSAD from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Overexpression of cysteine sulfinic acid decarboxylase stimulated by hepatocarcinogenesis results in autoantibody production in rats.
1996 · Cancer Res · RCR 0.3 · 16 citations - Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate-dependent enzyme, in endocrine autoimmune disease.
2004 · J Clin Endocrinol Metab · RCR 0.3 · 13 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.38
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- taurine biosynthetic process
- L-cysteine catabolic process to hypotaurine
- L-cysteine catabolic process to taurine
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CSAD as an antibody target. Whether an autoantibody or antibody against CSAD could matter depends on whether native CSAD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CSAD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CSAD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...